Cancers in organs such as the kidney, bladder, ureters, urethra, male genitalia, and prostate are genitourinary cancers.
Prostate cancer is the most common. It is slow growing, so an early detection through protein (PSA) helps to monitor its appearance. At our GCCC 360 Centre of Oncological Excellence we offer our patients a novel technique called SBRT (stereotactic body radiation therapy) to treat prostate cancer with curative intent, allowing higher, more precise and effective doses with the help of the insertion of a hydrogel that separates the prostate from the rectum, thus avoiding toxicity in healthy organs. This technique also allows the number of sessions to be shortened to only 5.
Kidney, bladder, ureter and urethral tumours early detected can be treated with surgery, but if the tumour is more advanced it requires other techniques such as immunotherapy and targeted therapies. Dr. Joaquim Bellmunt (leader of the medical oncology team and director of patient care at the 360 Centre of Oncological Excellence GCCC), is one of the most recognized oncologists in the world in the advancement of immunotherapy treatments and targeted therapies for this type of cancer. Innovation and experience are the basis for successful treatment.
There are two types of testicular cancer, seminoma and non-seminoma, depending on their development in the germ cells of the testicles. Treatment usually involves surgery to remove the damaged testicle. When the cancer is more advanced and has spread to other parts of the body, it may require chemotherapy or / and radiation therapy.
Type of cancer: Prostate cancer.